Peltan Ithan D, Rowhani-Rahbar Ali, Vande Vusse Lisa K, Caldwell Ellen, Rea Thomas D, Maier Ronald V, Watkins Timothy R
Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Washington School of Medicine, 1959 NE Pacific St, Box 356522, Seattle, WA, 98195, USA.
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Intermountain Medical Center, Salt Lake City, UT, USA.
Crit Care. 2016 Nov 16;20(1):371. doi: 10.1186/s13054-016-1541-9.
Acute traumatic coagulopathy (ATC) is a syndrome of early, endogenous clotting dysfunction that afflicts up to 30% of severely injured patients, signaling an increased likelihood of all-cause and hemorrhage-associated mortality. To aid identification of patients within the likely therapeutic window for ATC and facilitate study of its mechanisms and targeted treatment, we developed and validated a prehospital ATC prediction model.
Construction of a parsimonious multivariable logistic regression model predicting ATC - defined as an admission international normalized ratio >1.5 - employed data from 1963 severely injured patients admitted to an Oregon trauma system hospital between 2008 and 2012 who received prehospital care but did not have isolated head injury. The prediction model was validated using data from 285 severely injured patients admitted to a level 1 trauma center in Seattle, WA, USA between 2009 and 2013.
The final Prediction of Acute Coagulopathy of Trauma (PACT) score incorporated age, injury mechanism, prehospital shock index and Glasgow Coma Score values, and prehospital cardiopulmonary resuscitation and endotracheal intubation. In the validation cohort, the PACT score demonstrated better discrimination (area under the receiver operating characteristic curve 0.80 vs. 0.70, p = 0.032) and likely improved calibration compared to a previously published prehospital ATC prediction score. Designating PACT scores ≥196 as positive resulted in sensitivity and specificity for ATC of 73% and 74%, respectively.
Our prediction model uses routinely available and objective prehospital data to identify patients at increased risk of ATC. The PACT score could facilitate subject selection for studies of targeted treatment of ATC.
急性创伤性凝血病(ATC)是一种早期内源性凝血功能障碍综合征,高达30%的重伤患者会受到影响,这表明全因死亡和出血相关死亡的可能性增加。为了帮助识别处于ATC可能治疗窗口期的患者,并促进对其机制和靶向治疗的研究,我们开发并验证了一种院前ATC预测模型。
构建一个预测ATC的简约多变量逻辑回归模型(定义为入院国际标准化比值>1.5),使用了2008年至2012年间入住俄勒冈创伤系统医院的1963例重伤患者的数据,这些患者接受了院前护理但没有单纯头部损伤。使用2009年至2013年间美国华盛顿州西雅图市一级创伤中心收治的285例重伤患者的数据对预测模型进行验证。
最终的创伤急性凝血病预测(PACT)评分纳入了年龄、损伤机制、院前休克指数和格拉斯哥昏迷评分值,以及院前心肺复苏和气管插管情况。在验证队列中,与之前发表的院前ATC预测评分相比,PACT评分显示出更好的辨别能力(受试者操作特征曲线下面积为0.80对0.70,p = 0.032),并且可能校准性有所改善。将PACT评分≥196指定为阳性,ATC的敏感性和特异性分别为73%和74%。
我们的预测模型使用常规可得的客观院前数据来识别ATC风险增加的患者。PACT评分可为ATC靶向治疗研究的受试者选择提供便利。